Recently Featured

MHRA Seeks Stakeholder Evidence on Pre-Market Medical Device Regulation Changes

May 12, 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has initiated a stakeholder impact survey regarding proposed changes to the pre-market regulations for medical devices and in vitro diagnostics (IVDs) in Great Britain. This survey aims to gather critical insights from industry professionals to inform a comprehensive impact assessment, with a submission deadline set for 11:59…

ACROBiosystems Upgrades HEK293 License Solution for R&D Compliance

May 12, 2026
ACROBiosystems has announced an upgrade to its global licensing solution for HEK293 functional cell lines, aimed at enhancing compliance in biopharmaceutical research and development. This upgrade is significant as HEK293 cells are widely utilized in the production of biopharmaceuticals, serving as a critical platform for the development of vaccines and therapeutic proteins. The enhancement of…

BMS’ Sotyktu secures EC approval for psoriatic arthritis

May 12, 2026
Bristol Myers Squibb (BMS) has received approval from the European Commission for Sotyktu (deucravacitinib) as a treatment for active psoriatic arthritis (PsA). This milestone not only enhances BMS’s portfolio in the immunology space but also signifies a growing recognition of targeted therapies in managing chronic inflammatory conditions. PsA, affecting a significant portion of the population,…

Ongoing Cases